Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients

NCT00267943 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

639

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: telmisartan 80 mg + hydrochlorothiazide 25 mg

Sponsor

Boehringer Ingelheim